This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg. This study highlights the value of digital biomarkers that may enable instantaneous feedback for care providers in assessing the patient. Featured in an ACC.24
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
Despite significant advances in the diagnosis, prognostication, and treatment of thrombotic diseases over the past 3 decades, the adoption of findings stemming from translational biomarker research in clinical practice remains limited. They hold the promise of revolutionizing patientcare.
A jam-packed, expertly curated agenda will highlight the latest and most impactful advancements in cardiorenal metabolic medicine and protocols for future-focused, whole-patientcare.
“By pioneering a user-friendly device that enables frequent 12-lead ECGs over time and by coupling AI with our proprietary VECG technology that can go beyond a 12-lead ECG, HeartBeam is well-positioned to identify nuanced cardiac trends that could ultimately improve patientcare.”
These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patientcare plans. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.
One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patientcare and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.
Libby made a poignant observation, emphasizing that his LDL goal for patients is “ALARA: As Low As Reasonably Achieved.” Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I I am very inspired and rejuvenated at the 19th Annual CMHC.
Philips’ study reveals that AI-powered ECG biomarker technology may help to identify patients with significant intermittent bradyarrhythmia, potentially improving timely diagnosis and management.
Jimenez: Accucardia is an ECG-led diagnostics company, leveraging ECG as a broad biomarker for cardiology and beyond. That will allow physicians, clinicians, and technicians to dedicate more time to the most necessary areas, like direct patientcare or more complicated analysis which requires clinical intuition built from years of experience.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content